Vanguard羅素1000指數ETF VONE 深 滬
等待開盤 05-16 09:30:00 美东时间
334.69
-2.370
-0.70%
華盛通- 最 高334.69
- 今 開334.47
- 成交量 6.05万股
- 最 低 332.565
- 昨 收 337.06
- 總市值 793.05万
- 52周最高 337.76
- 市盈率 靜 --
- 換手率 255.34%
- 52周最低 261.8208
- 委 比 77.78%
- 總股本 2.37万
- 歷史最高 337.76
- 量 比 1.42
- 振 幅 0.63%
- 歷史最低 54.9562
- 每 手 1
- 風險率 16.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Goldman rebalances its long duration stock basket
The Goldman Sachs equity team has rebalanced its Long Duration Basket amid a recent rise in rates. "Equities usually struggle to digest sharp increases in interest rates, with long duration growth sto...
04-16 19:28
BRIEF-Novonesis Issues EUR 1.7 Billion In Bonds To Refinance Bridge Facility
BRIEF-Novonesis Issues EUR 1.7 Billion In Bonds To Refinance Bridge Facility March 16 (Reuters) - Novozymes A/S NSISb.CO : NOVONESIS ISSUES EUR 1.7 BILLION IN BONDS TO REFINANCE BRIDGE FACILITY NOVONESIS - BOND ISSUANCE TO REFINANCE BRIDGE FACILITY FOR FEED ENZYME ALLIANCE ACQUISITION Source text: I
03-16 20:21
BRIEF-Shionogi & Co Ltd - Planned Acquisition Of Global Rights To Tanabe Pharma's RADICAVA ORS And IV RADIC
Dec 22 (Reuters) - Shionogi & Co Ltd 4507.T: SHIONOGI EXPANDS RARE DISEASE PRESENCE WITH PLANNED ACQUISITION OF GLOBAL RIGHTS TO TANABE PHARMA CORPORATION'S RADICAVA ORS (EDARAVONE) AND IV RADIC TO PA...
2025-12-22 18:06
Best AI productivity beneficiary stocks - Goldman
Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...
2025-11-18 21:52
BRIEF-Novonesis And Noma In Partnership
Oct 23 (Reuters) - Novozymes A/S NSISb.CO: NOMA AND NOVONESIS PARTNER TO SCALE DELICIOUSNESS Source text: https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251023:nGNE8...
2025-10-23 19:06
BRIEF-Summit Therapeutics Raises $500 Million in Private Placement
Oct 22 (Reuters) - Summit Therapeutics Inc SMMT.O: SUMMIT THERAPEUTICS RAISES $500 MILLION IN PRIVATE PLACEMENT SUMMIT THERAPEUTICS INC - TO USE PROCEEDS FOR IVONESCIMAB DEVELOPMENT SUMMIT THERAPEUTIC...
2025-10-22 20:12
BRIEF-Novonesis And Novo Nordisk Will Explore New Solutions To Improve Metabolic Health
Sept 8 (Reuters) - Novozymes A/S NSISb.CO: NOVONESIS AND NOVO NORDISK WILL EXPLORE NEW SOLUTIONS TO IMPROVE METABOLIC HEALTH Source text: ID:nGNX6Lm3t7 Further company coverage: [NSISb.CO] ((Reuters.B...
2025-09-08 14:43
BRIEF-Revolution Medicines And Summit Therapeutics Enter Into Clinical Collaboration To Evaluate Combinations Of Three Ras(On) Inhibitors With Ivonescimab In Ras Mutant Tumors
Revolution Medicines Inc RVMD.O: REVOLUTION MEDICINES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL COLLABORATION TO EVALUATE COMBINATIONS OF THREE RAS(ON) INHIBITORS WITH IVONESCIMAB IN RAS MUTANT TUMO...
2025-06-30 20:15
Biogen Inc. Reports Q1 2025: Adjusted Earnings Per Share and Sales Growth Amid Currency Challenges
Biogen Inc. has released its financial results for the first quarter of 2025, reporting key figures and business updates. The company recorded a substantial increase in sales, driven by strong perform...
2025-05-01 18:47
BRIEF-ACS' FlatironDragados Integrates New York Tri-State Area Businesses
March 6 (Reuters) - ACS Actividades de Construccion y Servicios SA ACS.MC: FLATIRONDRAGADOS INTEGRATES NEW YORK TRI-STATE AREA BUSINESSES TRANSACTION EXPECTED TO BE COMPLETED IN Q2 FLATIRONDRAGADOS TO...
2025-03-06 23:48
